Global LFA-based Cardiac Competitive Landscape Professional Research Report 2025
Description
Global LFA-based Cardiac Competitive Landscape Professional Research Report 2025
Research Summary
LFA-based cardiac detection refers to the use of lateral flow immunoassays (LFAs) in the diagnosis of cardiac conditions. LFAs are rapid, low-cost, and easy-to-use diagnostic tools based on immune reactions between antigens and antibodies. In cardiac diagnosis, LFAs can detect cardiac markers, such as troponin, myoglobin, and creatine kinase, in blood samples to confirm the presence of a heart attack or other cardiac diseases. LFA-based cardiac tests are widely used in emergency rooms, clinics, and hospitals for quick and reliable diagnosis of cardiac conditions.
According to DIResearch's in-depth investigation and research, the global LFA-based Cardiac market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of LFA-based Cardiac include Thermo Fisher, Bio-Rad Laboratories, BD, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioMérieux, Clinical Diagnostics, LSI, Randox laboratories, Wondfo Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of LFA-based Cardiac. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global LFA-based Cardiac market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the LFA-based Cardiac market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of LFA-based Cardiac industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of LFA-based Cardiac Include:
Thermo Fisher
Bio-Rad Laboratories
BD
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
Clinical Diagnostics
LSI
Randox laboratories
Wondfo Biotech
LFA-based Cardiac Product Segment Include:
Troponin I
Troponin T
CK-MB
Myoglobin
Others
LFA-based Cardiac Product Application Include:
Laboratory Testing
Point-of-care Testing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global LFA-based Cardiac Industry PESTEL Analysis
Chapter 3: Global LFA-based Cardiac Industry Porter’s Five Forces Analysis
Chapter 4: Global LFA-based Cardiac Major Regional Market Size and Forecast Analysis
Chapter 5: Global LFA-based Cardiac Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global LFA-based Cardiac Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 LFA-based Cardiac Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 LFA-based Cardiac Product by Type
- 1.2.1 Troponin I
- 1.2.2 Troponin T
- 1.2.3 CK-MB
- 1.2.4 Myoglobin
- 1.2.5 Others
- 1.3 LFA-based Cardiac Product by Application
- 1.3.1 Laboratory Testing
- 1.3.2 Point-of-care Testing
- 1.4 Global LFA-based Cardiac Market Size Analysis (2020-2032)
- 1.5 LFA-based Cardiac Market Development Status and Trends
- 1.5.1 LFA-based Cardiac Industry Development Status Analysis
- 1.5.2 LFA-based Cardiac Industry Development Trends Analysis
- 2 LFA-based Cardiac Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 LFA-based Cardiac Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global LFA-based Cardiac Market Analysis by Regions
- 4.1 LFA-based Cardiac Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global LFA-based Cardiac Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global LFA-based Cardiac Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global LFA-based Cardiac Revenue Forecast by Region (2026-2032)
- 5 Global LFA-based Cardiac Market Size by Type and Application
- 5.1 Global LFA-based Cardiac Market Size by Type (2020-2032)
- 5.2 Global LFA-based Cardiac Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America LFA-based Cardiac Market Size by Type
- 6.4 North America LFA-based Cardiac Market Size by Application
- 6.5 North America LFA-based Cardiac Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe LFA-based Cardiac Market Size by Type
- 7.4 Europe LFA-based Cardiac Market Size by Application
- 7.5 Europe LFA-based Cardiac Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China LFA-based Cardiac Market Size by Type
- 8.4 China LFA-based Cardiac Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) LFA-based Cardiac Market Size by Type
- 9.4 APAC (excl. China) LFA-based Cardiac Market Size by Application
- 9.5 APAC (excl. China) LFA-based Cardiac Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America LFA-based Cardiac Market Size by Type
- 10.4 Latin America LFA-based Cardiac Market Size by Application
- 10.5 Latin America LFA-based Cardiac Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa LFA-based Cardiac Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa LFA-based Cardiac Market Size by Type
- 11.4 Middle East & Africa LFA-based Cardiac Market Size by Application
- 11.5 Middle East & Africa LFA-based Cardiac Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global LFA-based Cardiac Market Revenue by Key Manufacturers (2021-2025)
- 12.2 LFA-based Cardiac Competitive Landscape Analysis and Market Dynamic
- 12.2.1 LFA-based Cardiac Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Thermo Fisher
- 13.1.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Thermo Fisher LFA-based Cardiac Product Portfolio
- 13.1.3 Thermo Fisher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Bio-Rad Laboratories
- 13.2.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Bio-Rad Laboratories LFA-based Cardiac Product Portfolio
- 13.2.3 Bio-Rad Laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 BD
- 13.3.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 BD LFA-based Cardiac Product Portfolio
- 13.3.3 BD LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Roche
- 13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Roche LFA-based Cardiac Product Portfolio
- 13.4.3 Roche LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Hologic
- 13.5.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Hologic LFA-based Cardiac Product Portfolio
- 13.5.3 Hologic LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Abbott
- 13.6.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Abbott LFA-based Cardiac Product Portfolio
- 13.6.3 Abbott LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Siemens
- 13.7.1 Siemens Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Siemens LFA-based Cardiac Product Portfolio
- 13.7.3 Siemens LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Danaher
- 13.8.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Danaher LFA-based Cardiac Product Portfolio
- 13.8.3 Danaher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Alere
- 13.9.1 Alere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Alere LFA-based Cardiac Product Portfolio
- 13.9.3 Alere LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 BioMérieux
- 13.10.1 BioMérieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 BioMérieux LFA-based Cardiac Product Portfolio
- 13.10.3 BioMérieux LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Clinical Diagnostics
- 13.11.1 Clinical Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Clinical Diagnostics LFA-based Cardiac Product Portfolio
- 13.11.3 Clinical Diagnostics LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 LSI
- 13.12.1 LSI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 LSI LFA-based Cardiac Product Portfolio
- 13.12.3 LSI LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Randox laboratories
- 13.13.1 Randox laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Randox laboratories LFA-based Cardiac Product Portfolio
- 13.13.3 Randox laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Wondfo Biotech
- 13.14.1 Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Wondfo Biotech LFA-based Cardiac Product Portfolio
- 13.14.3 Wondfo Biotech LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 LFA-based Cardiac Industry Chain Analysis
- 14.2 LFA-based Cardiac Industry Raw Material and Suppliers Analysis
- 14.2.1 LFA-based Cardiac Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 LFA-based Cardiac Typical Downstream Customers
- 14.4 LFA-based Cardiac Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
